Welltower Inc. (WELL)

Overview News Price History Option Chain Discussions Forecast Stock Split Dividend History

Welltower Inc. stock is currently priced at $92.93, with a 24-hour trading volume of 2.22M. It has seen a +1.44% increased in the last 24 hours and a +0.92% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $91.42 pivot point. If it approaches the $93.19 resistance level, significant changes may occur.

Welltower Inc. Stock (WELL) Financials Data

Welltower Inc. (WELL) Revenue 2024

WELL reported a revenue (TTM) of $6.64 billion for the quarter ending December 31, 2023, a +13.26% rise year-over-year.

Welltower Inc. (WELL) Net Income 2024

WELL net income (TTM) was $340.09 million for the quarter ending December 31, 2023, a +140.84% increase year-over-year.

Welltower Inc. (WELL) Cash Flow 2024

WELL recorded a free cash flow (TTM) of $1.55 billion for the quarter ending December 31, 2023, a +19.48% increase year-over-year.

Welltower Inc. (WELL) Earnings per Share 2024

WELL earnings per share (TTM) was $0.64 for the quarter ending December 31, 2023, a +100.00% growth year-over-year.

Welltower Inc. Stock (WELL) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Fieweger Joshua	SVP, Chief Accounting Officer	Feb 13 '24	Option Exercise	0.00	6,569	0	17,746

Welltower Inc. Stock (WELL) Latest News

Welltower Inc. (NYSE: WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower™, a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.

Initiated	Deutsche Bank: Buy	Jan-30-24
Upgrade	JP Morgan: Neutral → Overweight	Dec-18-23
Downgrade	RBC Capital Mkts: Outperform → Sector Perform	Nov-28-23
Upgrade	Raymond James: Outperform → Strong Buy	Nov-09-23
Downgrade	JP Morgan: Overweight → Neutral	Oct-12-23
Initiated	Wedbush: Neutral	Oct-03-23
Downgrade	Evercore ISI: Outperform → In-line	Jul-14-23
Downgrade	Raymond James: Strong Buy → Outperform	Jun-23-23
Initiated	Wells Fargo: Overweight	Apr-20-23
Upgrade	Evercore ISI: In-line → Outperform	Apr-11-23
Upgrade	Citigroup: Neutral → Buy	Apr-06-23
Upgrade	Raymond James: Outperform → Strong Buy	Jan-09-23
Downgrade	Evercore ISI: Outperform → In-line	Nov-21-22
Reiterated	Credit Suisse: Outperform	Nov-01-22
Downgrade	Raymond James: Strong Buy → Outperform	Nov-01-22
Downgrade	Robert W. Baird: Outperform → Neutral	Oct-10-22
Resumed	Morgan Stanley: Overweight	Aug-31-22
Downgrade	SMBC Nikko: Outperform → Neutral	Aug-11-22
Upgrade	JP Morgan: Neutral → Overweight	Jun-22-22
Initiated	CapitalOne: Overweight	Jun-03-22
Upgrade	Credit Suisse: Neutral → Outperform	May-18-22
Upgrade	Scotiabank: Sector Perform → Sector Outperform	Apr-04-22
Initiated	Credit Suisse: Neutral	Feb-01-22
Upgrade	Mizuho: Neutral → Buy	Jan-20-22
Downgrade	JP Morgan: Overweight → Neutral	Dec-20-21
Resumed	Barclays: Overweight	Nov-17-21
Upgrade	BMO Capital Markets: Market Perform → Outperform	Aug-26-21
Upgrade	Berenberg: Hold → Buy	Aug-03-21
Initiated	Mizuho: Neutral	Jul-14-21
Upgrade	BMO Capital Markets: Underperform → Market Perform	Jun-25-21
Upgrade	Scotiabank: Sector Underperform → Sector Perform	Jun-23-21
Upgrade	Raymond James: Mkt Perform → Strong Buy	Jun-15-21
Initiated	Wolfe Research: Outperform	Jun-15-21
Upgrade	Evercore ISI: In-line → Outperform	Jun-14-21
Upgrade	CapitalOne: Equal Weight → Overweight	May-21-21
Upgrade	RBC Capital Mkts: Sector Perform → Outperform	May-03-21
Upgrade	BofA Securities: Neutral → Buy	Mar-30-21
Downgrade	BMO Capital Markets: Market Perform → Underperform	Jan-08-21
Initiated	Robert W. Baird: Outperform	Jan-06-21
Upgrade	JP Morgan: Neutral → Overweight	Dec-21-20
Upgrade	KeyBanc Capital Markets: Sector Weight → Overweight	Dec-14-20
Downgrade	Scotiabank: Sector Perform → Sector Underperform	Dec-03-20
Downgrade	Berenberg: Buy → Hold	Dec-02-20
Upgrade	BofA Securities: Underperform → Neutral	Nov-30-20
Downgrade	Wells Fargo: Overweight → Equal Weight	Nov-16-20
Downgrade	Evercore ISI: Outperform → In-line	Nov-13-20
Upgrade	Jefferies: Underperform → Hold	Nov-10-20
Downgrade	Mizuho: Buy → Neutral	Oct-16-20
Resumed	Stifel: Hold	Sep-02-20
Downgrade	Raymond James: Outperform → Mkt Perform	Aug-20-20
Initiated	Berenberg: Buy	Jul-22-20
Upgrade	Evercore ISI: In-line → Outperform	Jun-15-20
Downgrade	CapitalOne: Overweight → Equal Weight	May-07-20
Downgrade	Raymond James: Strong Buy → Outperform	Apr-29-20
Downgrade	Evercore ISI: Outperform → In-line	Mar-30-20
Downgrade	BofA/Merrill: Neutral → Underperform	Mar-23-20
Downgrade	Jefferies: Hold → Underperform	Mar-10-20
Downgrade	BMO Capital Markets: Outperform → Market Perform	Mar-09-20
Upgrade	Raymond James: Mkt Perform → Strong Buy	Feb-28-20